MDPI

Global $46.7B Cancer Biomarkers Market Outlook, 2035: MET Biomarkers Lead the Charge, Driven by Rising Incidence of Lung Cancer and Drug Development - ResearchAndMarkets.com

Retrieved on: 
星期三, 五月 8, 2024
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, Foundation Medicine, MSI, Lung cancer, Breast cancer, Blood, AI, MDPI, Skin cancer, Agilent Technologies, Prostate cancer, Biomarker, ALK, Kidney cancer, EGFR, OncoDNA, Cancer, Bladder cancer, Tempus, Son, Non-small-cell lung cancer, Frontiers Media, HER2, Colorectal cancer, Turbine, Thyroid cancer, ARUP Laboratories, Roche, Database, Therapy, Merck, NSCLC, Thermo Fisher Scientific, Nature, Publication, Laboratory, Survival, Insurance, BioMed Central, Nature Portfolio, Incidence, Drug development, Liver cancer, Liquid biopsy, MET, NTRK, CK Life Sciences, Endometrial cancer, Actuate, PD-L1, Patient, Gastrointestinal cancer, Physician, Neoplasm, Head, Medical imaging

Based on the type of cancer, the cancer biomarkers market is segmented into Breast Cancer, Prostate Cancer, Colorectum Cancer, Lung Cancer, Thyroid Cancer, Bladder Cancer, Melanoma, Non-Hodgkins Lymphoma, Endometrial Cancer, Kidney Cancer and Leukemia.

Key Points: 
  • Based on the type of cancer, the cancer biomarkers market is segmented into Breast Cancer, Prostate Cancer, Colorectum Cancer, Lung Cancer, Thyroid Cancer, Bladder Cancer, Melanoma, Non-Hodgkins Lymphoma, Endometrial Cancer, Kidney Cancer and Leukemia.
  • Currently, the market is driven by breast cancer biomarkers and lung cancer biomarkers; however, in the coming future, we anticipate cancer biomarker market for leukemia to grow at a significant pace.
  • The market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the companies involved in the cancer biomarkers market.
  • It is worth mentioning that Merck is conducting the maximum number of trials in this industry for various cancer indications, including bladder cancer, breast cancer, colorectal cancer, gastrointestinal cancer, gynecological cancer, head and neck cancer, kidney cancer, liver cancer, lung cancer, prostate cancer and skin cancer.

Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to Organs and Tumors

Retrieved on: 
星期一, 四月 22, 2024
LDLR, Small RNA, Cancer, Cell, Central nervous system disease, Tissue, MDPI, RNA, GBM, CNS, PDAC, Novo Nordisk, Family, Peptide, Neoplasm, Gene expression, Glioblastoma, Biotechnology, Ionis, Vaccine

Because the LDLR is differentially expressed in organs and is overexpressed in many cancers including glioblastoma multiforme (GBM) and pancreatic ductal adenocarcinoma (PDAC), the results open new opportunities for delivery to different organs or tumors.

Key Points: 
  • Because the LDLR is differentially expressed in organs and is overexpressed in many cancers including glioblastoma multiforme (GBM) and pancreatic ductal adenocarcinoma (PDAC), the results open new opportunities for delivery to different organs or tumors.
  • A vector belonging to this family of LDLR-targeting peptides is applied as a theragnostic agent for the diagnostic of GBM and PDAC.
  • “These results reinforce the potential of vectors to significantly improve the transport and delivery of therapeutic and imaging agents to improve the diagnostic and treatment of cancer and CNS disorders,” said Alexandre Tokay co-founder and CEO of Vect-Horus.
  • The study identified and optimized a family of peptide-based vectors that target the LDLR.

Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement

Retrieved on: 
星期一, 四月 1, 2024
Other Health, Research, Professional Services, Pharmaceutical, Medical Devices, Clinical Trials, Science, Biotechnology, Medical Supplies, Finance, Other Science, Health, TEVA, U.S. FDA, MDPI, Fluticasone, Patient, Doctor of Philosophy, MD, Asthma, Therapy, Teva, Pharmaceutical industry

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Launch Therapeutics, Inc., today announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA (TEV-‘248).

Key Points: 
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Launch Therapeutics, Inc., today announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA (TEV-‘248).
  • As part of the clinical collaboration agreement, Launch Therapeutics, a clinical development company backed by Abingworth and Carlyle, will have the lead role in the operational execution and management of the planned clinical trials, focused on accelerating Teva’s ICS-SABA (TEV-‘248) clinical research program.
  • Teva will recognize the funding as a reduction in research and development expenses and will retain full rights to the Company’s ICS/SABA program.
  • “Bridging together Teva's deep therapeutic expertise with Launch Therapeutics' profound clinical and operational expertise generates value to execute and accelerate this program.

Demeetra and Indiana University Biopesticide Platform Combining Gene Editing and Synthetic Biology Selected as a MDPI Journal Editor’s Choice Article

Retrieved on: 
星期三, 三月 20, 2024
Science, Other Science, Biotechnology, Research, Health, University, Genetics, Education, MDPI, Generation, Gene editing, Medicine, Saccharomyces cerevisiae, Transposase, Synthetic biology, Sterilization, RNA, Gene, Female, Indiana University, Engineering, Disease, Male, Mosquito control, Plant, Publication, Transgene, SIT, RNA interference, Therapy, Multimedia, Cas9

A pioneering study, authored by scientists from Demeetra and Indiana University, has been selected for the MDPI Journals Editor's Choice Articles , highlighting the impact of advanced gene editing in synthetic biology to produce biopesticides.

Key Points: 
  • A pioneering study, authored by scientists from Demeetra and Indiana University, has been selected for the MDPI Journals Editor's Choice Articles , highlighting the impact of advanced gene editing in synthetic biology to produce biopesticides.
  • View the full release here: https://www.businesswire.com/news/home/20240320823585/en/
    Demeetra and Indiana University research on gene edited yeast biopesticide was featured on the front cover of Fermentation.
  • According to MDPI “Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
  • “We wanted to engineer the ideal yeast platform for stable RNAi expression,” said Dr. Corey Brizzee, Director of Gene Editing at Demeetra.

REGENATIVE LABS' LATEST PUBLISHED STUDY DEMONSTRATES THE SAFETY AND EFFICACY OF WHARTON'S JELLY CONNECTIVE TISSUE ALLOGRAFT FOR ROTATOR CUFF TEARS

Retrieved on: 
星期四, 四月 4, 2024
Knee, MDPI, Stiffness, Shoulder, Safety, Hip, Wharton's jelly, Rotator cuff, Patient, Research, Rehabilitation, Quality of life, Manager, Efficacy, WOMAC, Regenerative medicine, Quality, Literature, Spine, Orthopedic surgery, Pain, Calendar, Physician, Injury, WJ, Medicine, Dentistry

PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.

Key Points: 
  • PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.
  • Patients in need of rotator cuff repairs often seek minimally invasive options, making Wharton's Jelly a promising alternative for musculoskeletal defects.
  • Utilizing the structural connective tissue allografts has allowed many patients to avoid surgery altogether and significantly improve their quality of life."
  • The study titled "Safety and Efficacy of Wharton's Jelly Connective Tissue Allograft for Rotator Cuff Tears," was published by MDPI and can be accessed in its entirety here.

Welltory Transforms Apple Watch Data Into Scientific Wellness Guidance

Retrieved on: 
星期一, 三月 18, 2024
Well, Wellness, IEEE, Heart rate, Apple Watch, Pressure, MDPI, Research, Exercise, System, Rest, Science, Mobile phone

REDWOOD CITY, Calif., March 18, 2024 /PRNewswire/ -- As wearables and apps collect users' health data, the potential for actionable insights has largely remained untapped. Welltory bridges this gap, combining science with proprietary technology to transform Apple Watch data into personalized guidance that goes beyond steps, calories, or heart rate. The app's new Today Screen lets users see the toll of sedentary stress on their bodies, shows them where it's coming from, and teaches them how to reduce its harm in real time.Results from the new feature's limited beta test show that the app's users who see the new Today Screen are twice as likely to come back the next week. Day 7 retention rates have grown by 163% for free users and by 74% for customers.

Key Points: 
  • REDWOOD CITY, Calif., March 18, 2024 /PRNewswire/ -- As wearables and apps collect users' health data, the potential for actionable insights has largely remained untapped.
  • Welltory bridges this gap, combining science with proprietary technology to transform Apple Watch data into personalized guidance that goes beyond steps, calories, or heart rate.
  • The adjusted results are then used to make sense of the day's heart rate data and differentiate sedentary stress from rest, exercise, neutral movement.
  • The new Today Screen has also repackaged Welltory's signature heart rate variability analysis — the product's scientific core backed by research Welltory has published in MDPI and IEEE .

China’s universities just grabbed 8 of the top 10 spots in one worldwide science ranking – without changing a thing

Retrieved on: 
星期三, 四月 3, 2024
MDPI, CWTS, Communication, Our Research, MIT, Education, Harvard University, School, Research, Welfare, Gold, Publishing, Sale, Faculty, Times Higher Education, Stanford University, UNESCO, Publication, Investment, Engineering, Chemical Reviews, Fire, Clarivate, Frontiers, Cell, SCI, Lancet

Rankings influence student matriculation numbers, attract talented faculty and justify donations from wealthy donors.

Key Points: 
  • Rankings influence student matriculation numbers, attract talented faculty and justify donations from wealthy donors.
  • University leaders rail against them, and some schools “withdraw” from them, but rankings are influential.
  • A radical shift in the data underlying rankings is about to upend the rankings world – largely in favor of China’s position.
  • China’s swift progress in science and technology, propelled by investments in research and university strength, has alarmed the United States and other nations.

Broader range of more sources

  • But careful curation makes it the gold standard of academic indexing and one that journals and authors aspire to join.
  • Reliance on curated databases is about to end with the introduction of rankings based on open data like that collected by OpenAlex.
  • OpenAlex claims to include over 100,000 journals – of highly varying quality and editorial practices – compared with SCI’s 9,200.

Reflecting China’s research productivity

  • As China has invested in education and grown its science and engineering capacity, many more people turn out scholarly articles.
  • From a very small number in the 1980s, China had 2.2 million scientists and engineers by 2023, based on UNESCO data.
  • China’s scholarly output of scientific and engineering articles shows a very rapid rise since the 1990s, with growth outpacing all other nations.
  • Open-access publishing services have grown rapidly and offer fast publication times, but there are questions about the quality of their journals.
  • Chinese researchers and their sponsoring institutions put a huge premium on publishing in international journals, even those hosted by questionable publishers.


Caroline Wagner does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Meet Eldie—The Only Gummy on The Market With High Potency, Zero Refined or Artificial Sweeteners, AND American-Grown Organic Elderberries

Retrieved on: 
星期四, 二月 8, 2024
Honey, Sambucus, Taylor & Francis, Education, NIH, LEAP, Small business, Trust, Box, Flower, Drink, Inflammation, MDPI, Monterey Bay, Polyphenol, Heart, Health, Iron, COVID-19, EBSCO, Human, Antioxidant, Farmer, Fruit, BMC, WBEC, Calcium, PubMed Central, Super Bowl, ScienceDirect, Coffee

Eldie joins the CA-based company’s line of fresh-pressed, American-grown culinary and wellness products, including: immune syrups, preserves, teas, and balsamic vinegars.

Key Points: 
  • Eldie joins the CA-based company’s line of fresh-pressed, American-grown culinary and wellness products, including: immune syrups, preserves, teas, and balsamic vinegars.
  • “While the process of crafting the immune gummy took more than 12 months, I refused to compromise on anything,” said Reneker.
  • “Our Eldies are made using top-notch sourcing; have 3X the amount of American-grown organic elderberries per serving than many leading brands on the market; contain only natural, zero-refined sweeteners; and incorporate more sustainable packaging.
  • An immune gummy you can feel really good about including in your family’s and your own daily wellness routine.”
    Eldie—The Gummy That Checks All The Boxes!

Digital Agriculture Market worth $36.0 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期一, 一月 29, 2024
Cloud, Control system, VRT, Research, Government, Vodafone, Farmer, Soil, Internet of things, Growth, HP, MDPI, John Deere, Automatic, Cereal, Hexagon AB, Artificial intelligence, European Parliament, Component, Developed country, Controller, Sorghum, Automation, Investment, Bayer, Cisco, Machine learning, Hardware, Environment, AGCO, Intelligence, Digital, Blockchain, Soybean, Digital economy, USD, IBM, Robotics, Trimble Inc., Region, Horticulture, Sprinkler, Agriculture

For instance, the Indian government is spearheading a technological revolution in agriculture, championing the widespread adoption of digital and innovative farming techniques throughout the nation.

Key Points: 
  • For instance, the Indian government is spearheading a technological revolution in agriculture, championing the widespread adoption of digital and innovative farming techniques throughout the nation.
  • As the sector continues to embrace innovation, automation and control systems stand as a key driver, propelling the digital agriculture market toward growth and efficiency.
  • The US is poised to maintain its dominant position within the North American digital agriculture market throughout the forecast period.
  • Farmers are increasingly recognizing the transformative impact of digital agriculture technologies on operational efficiency, resource optimization, and ultimately, crop yields.

Digital Agriculture Market worth $36.0 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期一, 一月 29, 2024
Cloud, Control system, VRT, Research, Government, Vodafone, Farmer, Soil, Internet of things, Growth, HP, MDPI, John Deere, Automatic, Cereal, Hexagon AB, Artificial intelligence, European Parliament, Component, Developed country, Controller, Sorghum, Automation, Investment, Bayer, Cisco, Machine learning, Hardware, Environment, AGCO, Intelligence, Digital, Blockchain, Soybean, Digital economy, USD, IBM, Robotics, Trimble Inc., Region, Horticulture, Sprinkler, Agriculture

For instance, the Indian government is spearheading a technological revolution in agriculture, championing the widespread adoption of digital and innovative farming techniques throughout the nation.

Key Points: 
  • For instance, the Indian government is spearheading a technological revolution in agriculture, championing the widespread adoption of digital and innovative farming techniques throughout the nation.
  • As the sector continues to embrace innovation, automation and control systems stand as a key driver, propelling the digital agriculture market toward growth and efficiency.
  • The US is poised to maintain its dominant position within the North American digital agriculture market throughout the forecast period.
  • Farmers are increasingly recognizing the transformative impact of digital agriculture technologies on operational efficiency, resource optimization, and ultimately, crop yields.